跳至主要内容
临床试验/IRCT20200923048815N1
IRCT20200923048815N1招募中2 期

Evaluation of the complementary effect of synbiotic adjuvant on inflammatory markers and clinical manifestations in patients with COVID-19

Esfahan University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 70 years(—)
性别
All

入选标准

  • Age 18-70 years old
  • Basic literacy
  • Writing ability and healthy memory
  • Mental conditions for continuing to attend the study and completing the consent form

排除标准

  • Simultaneous participation in other clinical trial studies
  • Having other acute and serious diseases
  • Regular and periodic consumption of special dietary supplements or special diets
  • Taking other probiotic supplements
  • Receive corticosteroids in full dose
  • People with pancreatitis, sepsis, dialysis, central venous and chronic diarrhea
  • People waiting for abdominal surgery
  • People with acute immune deficiencies such as AIDS
  • People with short bowel syndrome or are at risk for mesenteric ischemia
  • Pregnant women and mothers who are breastfeeding.

研究者

相似试验